Find the latest Replimune Group, Inc. (REPL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Replimune Group, Inc. (REPL) stock news and headlines to help you in your trading and investing decisions.

Interactive Chart for Replimune Group, Inc. (REPL), analyze all the data with a huge range of indicators.

Find the latest Replimune Group, Inc. (REPL) stock quote, history, news and other vital information to help you with your stock trading and investing.

Discover historical prices for REPL stock on Yahoo Finance. View daily, weekly or monthly format back to when Replimune Group, Inc. stock was issued.

Find the latest Replimune Group, Inc. (REPL) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

See the company profile for Replimune Group, Inc. (REPL) including business summary, industry/sector information, number of employees, business summary, corporate governance, …

Find out all the key statistics for Replimune Group, Inc. (REPL), including valuation measures, fiscal year financial statistics, trading record, share statistics and more.

Sep 24, 2025 · Replimune stock dives 54% over three months after the FDA rejects its RP1/Opdivo melanoma drug filing, delaying its first potential product launch.

WOBURN, Mass., July 22, 2025 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical stage biotechnology company pioneering the development of novel oncolytic …